Nigel Piggott, Ph.D.
Nigel Piggott, Senior Principal Scientist, Leica Microsystems, Newcastle, acquired his Ph.D. at the Edinburgh University in 1979. His doctoral thesis with the title ‘Synthesis of bacterial alginate by Pseudomonas aeruginosa’, sponsored by Tate & Lyle, was honored with the CASE Award. After working as a researcher for the University of Newcastle upon Tyne, he joined the former Vision Biosystems in 1994 as a Senior Research Associate. In 2002, Nigel Piggott became Antibody Development Manager, before becoming Principal Development Scientist in 2007. He has been holding his present position as Senior Principal Scientist since 2008.
ArticleCD99: Development and Evaluation of a Novel Monoclonal Antibody for use in Manual and Automated Immunohistochemistry15. May 2010 Authors: Gary McIntosh, Ph.D. , Michael Pinkney, Paul Scorer, Nigel Piggott, Ph.D. , Nicola Lawson, Ph.D. , Jeanette Doherty, Andrea Cleghorn Institutes: Leica Microsystems, Leica Biosystems, Wetzlar, GermanyCD99 is a transmembrane glycoprotein which is expressed in a wide range of tissues. Although its function is not fully understood it has been implicated in a variety of cellular processes including the homotypic aggregation of the T cells, apoptosis of immature thymocytes, up-regulation of T cell…
Article10. May 2010 Authors: Gary McIntosh, Ph.D. , Colin Tristram, Paul Scorer, Nigel Piggott, Ph.D. , Stephen Cowell, G. Menon Institutes: Leica Biosystems, Wetzlar, Germany, Newcastle University, Newcastle upon Tyne Hospitals NHS Foundation Trust, UK, Northern Institute for Cancer Research (NICR), Newcastle, UKThe North East Haematopathology Diagnostic Service, based at the Royal Victoria Infirmary in Newcastle upon Tyne, provides a regional service for expert assessment of lymphoproliferative and myeloproliferative disorders for a regional network of 14 NHS hospitals in the North East and Cumbria.
Article07. Sep 2009 Authors: Nigel Piggott, Ph.D. , Gary McIntosh, Ph.D. Institute: Leica Biosystems, Wetzlar, GermanyThe increased sensitivity of immunohistochemistry (IHC) over standard Hematoxylin and Eosin (H&E) staining has established the IHC technique in the study of many diseases. Herein we describe the utility of some NovocastraTM antibodies that can be used in the study of brain and muscle diseases.
Article01. Oct 2008 Authors: E Hyjek, Louise Flintoft, Nigel Piggott, Ph.D. , Mark Rees, Ph.D. , Elizabeth Udale, Victoria Reid, Ph.D. , Jeanette Doherty, Paul Scorer, Gary McIntosh, Ph.D. , A Chadburn, D M Knowles, I I Bansal Institutes: Leica Biosystems, Wetzlar, Germany, Weill Cornell Medical College, Department of Pathology & Laboratory Medicine, New York, NY, USACD33 Antigen Detection by PWS44 a New Monoclonal Antibody Reactive in Paraffin Tissues Sections: Pattern of Reactivity and Potential Diagnostic Utility.